Selonabant
N/A
Report date: 2025/05/29 16:54:23
NME
Base Information
Drug NameSelonabant
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVernalis Plc
China Registration ClassN/A
Develop Information
Active CompaniesAnebulo Pharmaceuticals Inc
Inactive CompaniesVernalis (R&D) Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksDrugBank